CoChat

Selected Patients with Unresectable Perihilar Cholangiocarcinoma (pCCA) Derive Long-Term Benefit from Liver Transplantation

Open access

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

Selected patients with unresectable perihilar cholangiocarcinoma (pCCA) derive long-term benefits from liver transplantation. Between 1993–2019, our group at Mayo Clinic performed 237 transplants for pCCA. With this experience, we note that two distinct patient populations comprise this group of pCCA patients: those with underlying primary sclerosing cholangitis (PSC) and those without identifiable risk factors termed sporadic or de novo pCCA. Long-term survival after transplant is better in PSC patients (74% five-year survival) than in those with de novo pCCA (58% five-year survival). Herein, we review the likely clinical factors contributing to the divergence in outcomes for these two patient populations. We also offer our insights on how further advances may improve patient selection and survival, focusing on the de novo pCCA patient population.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers12113157

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Intention-to-treat analysis of the overall survival of patients with perihilar cholangiocarcinoma (pCCA) after liver transplantation.
Figure 1 Intention-to-treat analysis of the overall survival of patients with perihilar cholangiocarcinoma (pCCA) after liver transplantation.CC BY · PubMed Central
Figure 2 Survival after liver transplantation of patients with de novo (black) and primary sclerosing cholangitis (PSC)-associated pCCA (red). Patients who were transplanted for PSC-associated pCCA had better long-term survival when compared to patients transplanted for de novo pCCA.
Figure 2 Survival after liver transplantation of patients with de novo (black) and primary sclerosing cholangitis (PSC)-associated pCCA (red). Patients who were transplanted for PSC-associated pCCA had better long-term survival when compared to patients transplanted for de novo pCCA.CC BY · PubMed Central
Figure 3 Tumor recurrence risk in percentage after liver transplantation in patients transplanted for de novo (black) and PSC-associated pCCA (red). A higher risk of tumor recurrence was observed in patients transplanted for de novo pCCA when compared to PSC-associated pCCA.
Figure 3 Tumor recurrence risk in percentage after liver transplantation in patients transplanted for de novo (black) and PSC-associated pCCA (red). A higher risk of tumor recurrence was observed in patients transplanted for de novo pCCA when compared to PSC-associated pCCA.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 44

Metadata

Authors
Azad, A. I., Rosen, C. B., Taner, T., Heimbach, J. K., & Gores, G. J.
Affiliations
  • Mayo Clinic (US)
  • Division of Transplantation Surgery, Mayo Clinic, Rochester, MN 55905, USA
Corresponding author
Gores, Gregory J.
Venue
Cancers
Publisher
MDPI AG
Published
2020-10-27
Volume
12
Issue
11
Pages
3157
ISSN
2072-6694 (ISSN-L)
OpenAlex
W3096452961
Cited by
41
References
25
Citations by year
2026: 5 · 2025: 8 · 2024: 13 · 2023: 5 · 2022: 6 · 2021: 3
FWCI
3.20
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Mayo Foundation for Medical Education and Research
Topics
  • Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
Keywords
hilar cholangiocarcinoma, liver transplantation, primary sclerosing cholangitis, patient selection, long-term survival, transplant outcomes, risk factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Selected Patients with Unresectable Perihilar Cholangiocarcinoma (pCCA) Derive Long-Term Benefit from Liver Transplantation. https://app.cochat.ai/papers/10.3390/cancers12113157
The paper
Azad, A. I., Rosen, C. B., Taner, T., Heimbach, J. K., & Gores, G. J. (2020). Selected Patients with Unresectable Perihilar Cholangiocarcinoma (pCCA) Derive Long-Term Benefit from Liver Transplantation. Cancers. https://doi.org/10.3390/cancers12113157

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.